A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001

计划入组 22 人 · 首次发布于 2011 年 7 月 27 日

A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus

计划入组 116 人 · 首次发布于 2011 年 7 月 29 日

H5N1 Milk Detection Study

计划入组 30 人 · 首次发布于 2025 年 2 月 27 日

mRNA vaccine (intramuscular/ pandemic influenza H5 virus infection)

ios-H5

Research Institute of Influenza

Russia

Sernova Corp

Canada

Hualan Biological Vaccine Inc.

China

Boehringer Ingelheim Introduces Novel Trivalent Vaccine Combining H5 Avian Flu Protection with Core Poultry Immunizations

European Medicines Agency Recommends Approval for Two Boehringer Ingelheim Avian Flu Vaccines

CEPI Partners with Samsung Biologics to Strengthen Global Vaccine Manufacturing for Future Pandemics